XTL Biopharmaceuticals Ltd. - stock earnings
XTLB Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | -215000 USD | ? USD |
| 2023Q2 | -364000 USD | ? USD |
| 2023Q1 | -1.6 million USD | ? USD |
| 2022Q4 | -1.3 million USD | -459000 USD |
| 2022Q3 | -1.4 million USD | ? USD |
| 2022Q2 | -357000 USD | ? USD |
| 2022Q1 | 1.3 million USD | ? USD |
| 2021Q4 | 2.1 million USD | 1.5 million USD |
| 2021Q3 | -510000 USD | ? USD |
| 2021Q2 | -865000 USD | ? USD |
| 2021Q1 | 286000 USD | ? USD |
| 2020Q4 | 205000 USD | 28000 USD |
| 2020Q3 | -590000 USD | ? USD |
| 2020Q2 | -932000 USD | ? USD |
| 2020Q1 | 27000 USD | ? USD |
| 2019Q4 | -1.1 million USD | 69000 USD |
| 2019Q3 | -1.3 million USD | ? USD |
| 2019Q2 | -2.9 million USD | ? USD |
| 2019Q1 | 3.9 million USD | ? USD |
| 2018Q4 | 1.0 million USD | 52000 USD |
| 2018Q3 | 1.0 million USD | ? USD |
| 2018Q2 | 34000 USD | 2.2 million USD |
| 2018Q1 | 875000 USD | ? USD |
| 2017Q4 | -2000 USD | 29000 USD |
| 2017Q3 | 1.6 million USD | ? USD |
| 2017Q2 | -1.4 million USD | ? USD |
| 2017Q1 | -977000 USD | ? USD |
| 2016Q4 | -1.2 million USD | ? USD |
| 2016Q3 | -286000 USD | ? USD |
| 2016Q2 | -477000 USD | ? USD |
| 2016Q1 | -577000 USD | ? USD |
| 2015Q4 | -2.4 million USD | ? USD |
| 2015Q3 | -443000 USD | ? USD |
| 2015Q2 | -427000 USD | ? USD |
| 2015Q1 | -768000 USD | -1.3 million USD |
| 2014Q4 | -768000 USD | -1.3 million USD |
| 2014Q3 | -510000 USD | 287000 USD |
| 2014Q2 | -563000 USD | 380000 USD |
| 2014Q1 | -1.2 million USD | 711000 USD |
| 2013Q4 | -1.2 million USD | 711000 USD |
| 2013Q3 | 549000 USD | 473000 USD |
| 2013Q2 | -1.0 million USD | 512000 USD |
| 2013Q1 | -296000 USD | 938000 USD |
| 2012Q4 | -296000 USD | 938000 USD |
| 2012Q3 | -50000 USD | 343000 USD |
| 2012Q2 | -675000 USD | ? USD |
| 2012Q1 | -369000 USD | ? USD |
| 2011Q4 | -288000 USD | ? USD |
| 2011Q3 | -337000 USD | ? USD |
| 2011Q2 | -280000 USD | ? USD |
| 2011Q1 | -315000 USD | ? USD |
| 2010Q4 | -315000 USD | ? USD |
| 2010Q3 | -290000 USD | ? USD |
| 2010Q2 | -316000 USD | ? USD |
| 2010Q1 | -288000 USD | ? USD |
| 2009Q4 | -288000 USD | ? USD |
| 2009Q3 | 9000 USD | ? USD |
| 2009Q2 | 1.2 million USD | ? USD |
| 2009Q1 | 801000 USD | -3.7 million USD |
| 2008Q4 | 801000 USD | -3.7 million USD |
| 2008Q3 | -1.3 million USD | 2.0 million USD |
| 2008Q2 | -3.6 million USD | 2.0 million USD |
| 2008Q1 | -3.6 million USD | 2.0 million USD |
| 2007Q4 | 17.5 million USD | 247000 USD |
| 2007Q3 | -6.2 million USD | 226000 USD |
| 2007Q2 | -7.3 million USD | 114000 USD |
| 2007Q1 | -7.3 million USD | 114000 USD |
| 2006Q4 | -3.9 million USD | 113000 USD |
| 2006Q3 | -3.9 million USD | 114000 USD |
| 2006Q2 | -3.6 million USD | 114000 USD |
| 2006Q1 | -4.5 million USD | 294000 USD |
| 2005Q4 | -4.5 million USD | 294000 USD |
| 2005Q3 | -4.5 million USD | 295000 USD |
| 2005Q2 | -2.5 million USD | 1.3 million USD |
| 2005Q1 | -2.5 million USD | 1.3 million USD |
| 2004Q4 | -4.1 million USD | 862000 USD |
| 2004Q3 | -4.1 million USD | 864000 USD |
| 2004Q2 | -5.0 million USD | 359000 USD |
| 2004Q1 | -4.1 million USD | 864000 USD |
XTLB Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -2.2 million USD | ? USD |
| 2022 | -2.3 million USD | -459000 USD |
| 2021 | 1.9 million USD | 1.5 million USD |
| 2020 | -616000 USD | 28000 USD |
| 2019 | -1.3 million USD | 69000 USD |
| 2018 | 3.0 million USD | 52000 USD |
| 2017 | -781000 USD | 29000 USD |
| 2016 | -2.5 million USD | 23000 USD |
| 2015 | -4.3 million USD | -6000 USD |
| 2014 | -2.5 million USD | 41000 USD |
| 2013 | -2.5 million USD | 2.4 million USD |
| 2012 | -1.4 million USD | 938000 USD |
| 2011 | -1.2 million USD | ? USD |
| 2010 | -1.3 million USD | ? USD |
| 2009 | 2.6 million USD | ? USD |
| 2008 | -9.2 million USD | 5.9 million USD |
| 2007 | -24.9 million USD | 907000 USD |
| 2006 | -15.1 million USD | 454000 USD |
| 2005 | -14.0 million USD | 3.2 million USD |
| 2004 | -16.5 million USD | 3.5 million USD |
| 2003 | -14.3 million USD | ? USD |
| 2002 | -17.1 million USD | ? USD |
| 2001 | -12.7 million USD | ? USD |
XTLB
Price: $2.60
52 week price:
Payout Ratio Range:
Earnings Per Share: -0.40 USD
P/E Ratio: -2.29
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 5727
Ebitda: -1.4 millionMarket Capitalization: 15.0 million